Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The study measure multiple neurohormones in patients with heart failure being treated with
Sacubitril/Valsartan in increasing doses over an 8 week period.